Scope
The IAP paediatric emergency chapter describes triage, first aid, stabilization, antivenom-related care, monitoring and disposition after snakebite in children. It is an Indian emergency-care guide. This summary preserves the distinction between suspected envenomation requiring observation and asymptomatic children who should not receive prophylactic antivenom.
Written by House with AI assistance · AI-assisted source check 29 October 2026.
This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.
Triage and severity assessment
- Look immediately for airway or breathing compromise: ptosis, difficulty swallowing, pooled secretions, stridor and paradoxical chest movement are warning signs. Also assess hypotension, tachycardia, delayed capillary refill and cold peripheries for shock. [1]
- Progressive paralysis, altered mental status, seizures, bulbar weakness or inability to sit or hold the neck indicate neurological deterioration. Rapidly spreading swelling, blistering, necrosis or severe local pain and bleeding from mucosa, urine, stool or puncture sites also warrant urgent attention. [1]
- Use serial neurological and vital-sign assessment. The chapter lists GCS for neurological progression and PEWS for deterioration; for suspected viper coagulopathy, blood remaining unclotted after 20 minutes in a clean glass tube is abnormal on the 20WBCT. [1]
First aid and stabilization
- Reassure the child and family, splint the bitten limb, remove constricting clothing or jewellery near the bite, keep the child calm and arrange rapid transport to hospital. [1]
- Avoid incision, suction, burning, chemicals and tight tourniquets. Do not delay care to capture or kill the snake, use native remedies, or postpone referral when antivenom is unavailable. [1]
- Provide oxygen, suction secretions and prepare for intubation when bulbar paralysis or respiratory failure is present. Establish intravenous access, monitor blood pressure and start fluids for hypotension. [1]
Antivenom and supportive treatment
- The chapter identifies Indian polyvalent antivenom as specific treatment covering the Big Four snakes. Children receive the same antivenom dose as adults because dose depends on venom load rather than body weight; further doses depend on clinical response and 20WBCT. [1]
- Do not administer antivenom prophylactically to asymptomatic children. Keep intramuscular adrenaline 0.01 mg/kg, maximum 0.5 mg, ready at the bedside for anaphylaxis. [1]
- The chapter lists atropine with neostigmine under monitoring for neurotoxic paralysis. Persistent coagulopathy after antivenom may require fresh frozen plasma or cryoprecipitate. [1]
- Use paracetamol for pain and avoid NSAIDs. Provide tetanus prophylaxis; broad-spectrum antibiotics are reserved for necrosis or cellulitis rather than routine use. [1]
Investigations and monitoring
- Bedside assessment includes 20WBCT and urine testing for haematuria. The listed laboratory work-up includes blood count, coagulation tests, fibrinogen, renal and liver function, electrolytes, creatine kinase and blood grouping. [1]
- Use imaging according to the clinical problem: the chapter lists ultrasound for abdominal bleeding or acute kidney injury, and chest radiography for respiratory distress. Follow serial GCS, cranial-nerve findings and vital capacity by bedside spirometry where available. [1]
Admission, discharge and documentation
- Admit children with suspected envenomation even when initial signs are absent. Ventilatory support for neuroparalysis, shock, refractory bleeding or DIC, and acute kidney injury or oliguria are indications for intensive care; local envenomation without systemic features can be managed on a ward. [1]
- For children who have received antivenom, the stated discharge criteria include absence of symptoms for >24 hours after the last antivenom, normal coagulation and renal tests, no progression at the bite site, and caregiver education about warning signs and follow-up. [1]
- Record bite history, pre-hospital measures, local findings, serial observations, timed laboratory results, antivenom dose and timing, batch and manufacturer, adverse reactions, consent, and follow-up advice. [1]
Limitations and use
- This is a paediatric emergency chapter, not a complete species-specific snakebite protocol.
- The summary does not reproduce the chapter’s initial antivenom preparation regimen or all supportive drug doses; consult the original protocol and the product-specific emergency pathway.
- Some running page headings in the source name other emergency topics; the summarized content is confined to the snakebite chapter and its stated recommendations.
- This excerpt does not define an observation duration for untreated suspected bites. The after-antivenom discharge criterion does not imply that asymptomatic children should receive antivenom.
This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.
Summary sources
- Snake Bite Management in Children
Selected recommendation material consulted
Publication details
- Issuing organisation
- IAP
- Resource type
- Practice guideline · House clinical summary
- Source setting
- India
The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.